BLACK BIRD BIOTECH, INC.

3505 Yucca Drive – Suite 104

Flower Mound, Texas 75028

September 22, 2021

VIA EDGAR

Mr. Gregory Herbers

Office of Manufacturing

Division of Corporation Finance

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Re:	Black Bird Biotech, Inc. (the “Company”)
	Post-qualification Amendment to Offering Statement on Form 1-A (the “Post-Qualification Amendment”) Filed September 16, 2021 Commission File No. 024-11621

Dear Mr. Herbers:

On behalf of the Company, I respectfully request that the qualification date of the Post-Qualification Amendment be accelerated and that the Post-Qualification Amendment be declared qualified September 24, 2021, at 3:00 p.m. EST, or as soon thereafter as is reasonably practicable.

In making this request, the Company acknowledges the following:

- should the Securities and Exchange Commission (the “Commission”) or the Staff, acting pursuant to delegated authority, declare the filing qualified, it does not foreclose the Commission from taking any action with respect to the filing;

- the action of the Commission or the staff, acting pursuant to delegated authority, to declare the filing qualified does not relieve the Company from its full responsibility for the adequacy and accuracy of disclosure in the filing; and

- the Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities law of the United States.

Very truly yours,

/s/ Fabian G. Deneault

Fabian G. Deneault

President

Black Bird Biotech, Inc.